Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

GENSIA, SANDOZ TO PURSUE DIABETES DRUGS

Jan. 9, 1992

IMMUNOMEDICS TO GET BROAD PATENT

Jan. 9, 1992

CALGENE TO GET ANTISENSE PATENT

Jan. 9, 1992

BIOMIRA STOCK CONTINUES TO RISE

Jan. 9, 1992

MGI CONVERTS PREFERRED STOCK

Jan. 9, 1992

SPAIN APPROVES CYTOGEN'S ONCOSCINT

Jan. 9, 1992

NOVA GETS PATENT FOR LEUMEDIN COMPOUNDS

Jan. 9, 1992

GLYCOMED RECEIVES PATENT NOTICE

Jan. 9, 1992

IMRE ARTHRITIS TREATMENT TRIALS APPROVED

Jan. 9, 1992

MOLECULAR BIO IMAGING AGENT ENTERS PHASE I

Jan. 9, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.